#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Aaron Glieberman Email
Director Platform Development . MelliCell
Watertown, MA
Locationa***************@mellicell.com
Primary EmailHow to contact Aaron Glieberman
Join and see Aaron's contact info for free!Current Roles
Employees:
11Revenue:
$1.7MAbout
MelliCell develops therapeutics for diabetes and obesity using a proprietary in vitro model of weight gain in human fat cells. Our core technology enables discovery of therapeutic targets and leads, while reducing the time and money required for efficacy screening. It efficiently turns human stem cells into fat cells and accelerates their growth to sizes that are thousands of times larger than conventional limits and that match the sizes of mature fat cells in adults. Changes in fat cell size are how adults gain (or lose) weight, and increased fat cell size predicts diabetes better than obesity per se. The products we develop will treat obesity and diabetes by shrinking fat cell size and by preventing compromised metabolism in enlarged cells. We differentiate ourselves from competing therapies (e.g. GLP-1 analogs, SGLT2 inhibitors, anorexiants, intestinal lipase inhibitors, insulin secretagogues) by focusing on adipocyte-intrinsic mechanisms of action enabled by our core technology.MelliCell Address
Watertown, MA 02472, USWatertown, MA